Proton pump inhibitor use represents an independent risk factor for myocardial infarction.
about
Widespread use of gastric acid inhibitors in infants: Are they needed? Are they safe?Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General PopulationClinical Implications of Emerging Data on the Safety of Proton Pump Inhibitors.Proton pump inhibitor monotherapy and the risk of cardiovascular events in patients with gastro-esophageal reflux disease: a meta-analysis.Impact of concomitant use of proton pump inhibitors and clopidogrel or ticagrelor on clinical outcomes in patients with acute coronary syndromeAsymmetric Dimethylarginine versus Proton Pump Inhibitors Usage in Patients with Stable Coronary Artery Disease: A Cross-Sectional Study.How May Proton Pump Inhibitors Impair Cardiovascular Health?Idiopathic Pulmonary Fibrosis: Novel Concepts of Proton Pump Inhibitors as Antifibrotic Drugs.Omeprazole impairs vascular redox biology and causes xanthine oxidoreductase-mediated endothelial dysfunction.The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus.Weaning of proton pump inhibitors in patients with suspected laryngopharyngeal reflux disease.The Metabolism of Clopidogrel: CYP2C19 Is a Minor Pathway.Proton-Pump Inhibitor Use and the Risk of First-Time Ischemic Stroke in the General Population: A Nationwide Population-Based Study.Risk of pneumonia in patients with gastroesophageal reflux disease: A population-based cohort study.Can Endothelial Injury Provide the Passage to Explain the Vascular Effects of Proton Pump Inhibitors?Long-term use of proton pump inhibitors, dose-response relationship and associated risk of ischemic stroke and myocardial infarction.Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials.
P2860
Q28072141-3684F5CF-C9C8-4E81-869E-41AF1A8D6531Q28548045-7A9A49AA-C817-4330-8771-24107BEC23A6Q31157434-9F20B5DD-419D-4CFC-B803-4D6314FBE330Q36117874-897752EA-82A6-40B7-BE1C-8812272BCA43Q36784692-79E8DB3C-507B-46A2-8594-5CA3A0AA4CE6Q36846899-E7A0423B-95ED-42A0-A8E5-7DE252D1946FQ36892867-AB9DB24B-F4BF-49CB-9D41-94532224FC5CQ37013159-E2AEAD01-63DC-4E6B-9DA1-9A89A5FDFD3AQ37171592-6A591323-800B-4F6B-B420-5E578C27627AQ37709906-1A1D5991-2246-4E86-BDF4-A07496533D35Q38668590-49EFF92E-2618-47C1-938F-C06B4F1B62D9Q38838327-64ACCBDB-A2A3-4A75-AFFF-3B4AF9639021Q40248473-64BF1686-690C-48BB-B1AF-47FC8EAF09C6Q41512453-69F13FB4-B524-46C4-9B50-6FBA71331F73Q42333495-ECD949EF-2151-41F3-8131-2FA3D3244814Q48200162-F7DFAE56-D4FA-4EAF-A91A-17C7604FE856Q52687792-180BC361-7D93-4CEB-A9EA-46A1DBEF21E1
P2860
Proton pump inhibitor use represents an independent risk factor for myocardial infarction.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Proton pump inhibitor use repr ...... tor for myocardial infarction.
@en
type
label
Proton pump inhibitor use repr ...... tor for myocardial infarction.
@en
prefLabel
Proton pump inhibitor use repr ...... tor for myocardial infarction.
@en
P2093
P1476
Proton pump inhibitor use repr ...... tor for myocardial infarction.
@en
P2093
Chia-Jen Shih
Shuo-Ming Ou
Szu-Yuan Li
Tzeng-Ji Chen
Yung-Tai Chen
P304
P356
10.1016/J.IJCARD.2014.09.036
P407
P577
2014-09-28T00:00:00Z